The first Sarepta Therapeutics trade was made in Q3 2017.
Since then Joel Greenblatt bought shares five more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2022 and Q2 2023.
Avg closing price
Price range
Sold -2.85 Thousand shares
Q2 2023
Avg closing price
$128.95
Price range
$106.40
-
$157.19
Sold 33.0% shares (-1.41 Thousand shares)
Q1 2023
Avg closing price
$129.72
Price range
$117.53
-
$155.99
Sold 69.3% shares (-9.61 Thousand shares)
Q4 2022
Avg closing price
$115.88
Price range
$100.39
-
$132.13
Increased shares by 164.2% (+8.62 Thousand shares)
Q3 2022
Avg closing price
$100.79
Price range
$75.71
-
$119.24
Sold 57.8% shares (-7.19 Thousand shares)
Q2 2022
Avg closing price
$73.57
Price range
$62.69
-
$88.44
New holding (+12.4 Thousand shares)
Q1 2022
Avg closing price
$76.58
Price range
$63.15
-
$90.42
Sold -1.6 Thousand shares
Q1 2020
Avg closing price
$114.31
Price range
$82.38
-
$131.64
New holding (+1.6 Thousand shares)
Q4 2019
Avg closing price
$100.93
Price range
$76.53
-
$135.58
Sold -3.95 Thousand shares
Q3 2019
Avg closing price
$118.10
Price range
$72.81
-
$156.91
Sold 1.8% shares (-71 shares)
Q2 2019
Avg closing price
$121.53
Price range
$112.21
-
$151.95
Sold 7.4% shares (-319 shares)
Q1 2019
Avg closing price
$128.56
Price range
$106.67
-
$151.68
Sold 66.5% shares (-8.61 Thousand shares)
Q4 2018
Avg closing price
$125.06
Price range
$97.32
-
$148.76
Increased shares by 30.5% (+3.03 Thousand shares)
Q3 2018